We recently compiled a list of the 12 Stocks That Will Double in 2025. In this article, we are going to take a look at where PACS Group, Inc. (NYSE:PACS) stands against the other stocks.

Alterity Therapeutics ATHE shares moved upwards by 95.9% to $5.7 during Thursday's pre-market session. The market value of their outstanding shares is at $49.8 million. T ...

We recently compiled a list of the Jim Cramer Discussed These 12 Stocks Amidst The DeepSeek AI Selloff. In this article, we are going to take a look at where UnitedHealth Group Incorporated ...

EyePoint's Duravyu, a potential "best-in-class" therapy for Wet AMD and DME, could disrupt the market with fewer injections ...

While RFK Jr. is likely to lead the Department of HHS, he will be limited in his ability to stop the continued innovation and ...

Cardinal Health had $210 billion in pharmaceutical and specialty drugs sales in fiscal 2024, up 11% year-over-year, helped in large part by GLP-1 sales. In Q4, segment sales rose 13% to $55 billion, ...

WisdomTree U.S. SmallCap Dividend Fund offers a 2.8% yield but underperforms peers, with a sector allocation impacting growth potential. Learn more on DES stock here.

Cigna forecast annual profit below Wall Street expectations on Thursday and missed estimates for the fourth quarter, hurt by higher medical costs for a type of employer-sponsored healthcare plan.

Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.

One of the most difficult sectors to invest in is the healthcare sector. Not only do you have to be nuanced in the ways of the stock market but you also have to have a deep understanding of medicines, ...

Healthcare stocks have been under the weather for the past few years, underperforming the broader market’s rally despite ...